A Cry for Help? FDA Bares Concerns in NEJM
The most senior FDA executives went public with their worries, frustration even, we suspect, impotence regarding the plethora of stem cells therapies in the market last November. And that article, which appeared in the New England Journal of Medicine just keeps growing in influence. Here is what Celia Whitten, Peter Marks and Robert Califf said.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Orthopedics This Week?
This episode is 14 minutes long.
When was this Orthopedics This Week episode published?
This episode was published on May 11, 2017.
Can I download this Orthopedics This Week episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.